Austin, TX, June 17, 2015 --(PR.com
)-- Today Bioo Scientific announced the launch of the MaxSignal® TMB (3,3’,5,5’ – tetramethylbenzidine) Microwell Substrate Solution, a stable, one-component, ready-to-use TMB formulation which has already been incorporated into hundreds of different types of ELISA kits. This TMB simplifies ELISAs for the end user, while increasing accuracy by reducing potential errors.
The MaxSignal TMB Microwell Substrate Solution has a shelf life of 3 years when stored at 2º - 8ºC. This reagent has undergone rigorous stability testing to measure both its stability and performance over a prolonged period of time. This testing has demonstrated that the MaxSignal TMB Microwell Substrate Solution is more stable over long term storage than TMB obtained from other leading manufacturers.
Unlike most other commercially available substrates, this product contains no DMF or DMSO and is non-carcinogenic. This reagent is also manufactured to the international quality standard ISO 9001:2008 (ISO CI#: SARA-2009-CA-0114-A).
The MaxSignal TMB Microwell Substrate Solution has been incorporated into Bioo Scientific’s complete line of MaxSignal® ELISA Kits for the detection of toxins, pesticides, antibiotics, hormones and other veterinary drugs in food and feed samples. Additionally it is incorporated into the MaxDiscovery™ Cytokine and Reporter Assay ELISA Kits. These kits are manufactured to the international quality standard ISO 9001:2008 (ISO CI#: SARA-2009-CA-0114-A).
About Bioo Scientific
Bioo Scientific Corporation is an Austin, TX based biotechnology company that provides innovative solutions to the life science industry. As a world leader in food safety testing, Bioo Scientific is dedicated to improving the safety of the world’s food and feed supply by developing accurate, affordable tools which allow companies to readily screen for microbial and industrial contaminants, natural toxins, hormones, antibiotics, pesticides and other residues.
Bioo Scientific’s research product lines include reagents optimized to facilitate in vivo and in vitro delivery of nucleic acids; a complete portfolio of next-generation sequencing (NGS) library prep kits that reduce bias and increase the sensitivity, flexibility and speed; ELISA kits for cytokine detection and reporter assays; and preclinical chemistry assays to monitor in vivo toxicity by measuring liver and heart function in serum samples in model organisms.
Bioo Scientific has been awarded numerous Small Business Innovation Research (SBIR) grants that support innovative product development activities from agencies such as the National Institutes of Health (NIH), the United States Department of Agriculture (USDA), Food and Drug Administration (FDA), the National Science Foundation (NSF), and Department of Defense (DOD). The company has also been awarded the Tech Innovation Award and the Greater Austin Business Export Award highlighting its international business activities. For more information about Bioo Scientific, visit www.biooscientific.com.